ELOXEloxx Pharmaceuticals, Inc.

About Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals, Inc. (ELOX) is a Biotechnology company headquartered in Arlington, MA, United States whose shares trade over-the-counter on the Expert Market tier.

The primary business of the Company is to utilize our patented and patent-pending technology related to antibody genes, antibody discovery technology, modified cow antibodies, and antibody drug candidates, and related technologies for human therapeutic applications to develop novel approaches to treat cancer and inflammatory diseases.

ELOX key facts

Ticker symbol

ELOX

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Arlington, MA, United States

Country of incorporation

US

Year of incorporation

1999

Employees

17

Estimated market cap

$330.053 (as of Apr 11, 2025)

Shares outstanding

3,300,528

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

6/30

Latest filing

8K Report (Mar 25, 2024)

Eloxx Pharmaceuticals, Inc. leadership

• Robert Ward — CEO
• Gregory Weaver — CFO
• Miguel de los Rios — VP, R&D
• Dr. Pedro Huertas — Chief Med. Officer
• Brett Hagen — Controller
• Barbara Ryan — IR

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with E